Which antiplatelet monotherapy is best for CAD secondary prevention?
Antiplatelet monotherapy with clopidogrel or ticagrelor may be safer and more effective for secondary prevention of cardiovascular events than aspirin alone, results from a large…
Tag: Antiplatelet
A GP guide to spontaneous coronary artery dissection
Significant number of MIs are related to non-athero-sclerotic mechanisms, which require specific diagnostic and therapeutic strategies (see figure 1). Takotsubo syndrome, coronary vasospasm, myocarditis, coronary…
Bleeding risk ‘predicts ticagrelor benefit’
Cardiologists have pinpointed two risk factors that could assist clinical decision-making on dual antiplatelet therapy.
Patients missing out on optimum therapy post-MI: Aust study
A big data linkage study shows low rates of dispensing post-discharge and wide variation among hospitals.
Safe to drop aspirin from dual antiplatelet therapy after PCI: study
Results from a meta-analysis show the risk-benefit assessment is favourable, researchers from Harvard University say.
Anticoagulants with antiplatelets ‘questionable’ in some with AF
Large registry study suggests higher risk of stroke and bleeding on dual therapy.
